Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients.
Manousou P, Kalambokis G, Grillo F, Watkins J, Xirouchakis E, Pleguezuelo M, Leandro G, Arvaniti V, Germani G, Patch D, Calvaruso V, Mikhailidis DP, Dhillon AP, Burroughs AK. Manousou P, et al. Liver Int. 2011 May;31(5):730-9. doi: 10.1111/j.1478-3231.2011.02488.x. Epub 2011 Mar 6. Liver Int. 2011. PMID: 21457446 Free article.
Non-alcoholic fatty liver disease.
Maurice J, Manousou P. Maurice J, et al. Among authors: manousou p. Clin Med (Lond). 2018 Jun;18(3):245-250. doi: 10.7861/clinmedicine.18-3-245. Clin Med (Lond). 2018. PMID: 29858436 Free PMC article. Review.
The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease.
Chambers ES, Byrne CS, Rugyendo A, Morrison DJ, Preston T, Tedford C, Bell JD, Thomas L, Akbar AN, Riddell NE, Sharma R, Thursz MR, Manousou P, Frost G. Chambers ES, et al. Among authors: manousou p. Diabetes Obes Metab. 2019 Feb;21(2):372-376. doi: 10.1111/dom.13500. Epub 2018 Sep 16. Diabetes Obes Metab. 2019. PMID: 30098126 Free PMC article. Clinical Trial.
Non-alcoholic fatty liver disease and cardiovascular risk: an update.
Mullish BH, Forlano R, Manousou P, Mikhailidis DP. Mullish BH, et al. Among authors: manousou p. Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1175-1177. doi: 10.1080/17474124.2018.1533117. Epub 2018 Oct 16. Expert Rev Gastroenterol Hepatol. 2018. PMID: 30791787 Free article. No abstract available.
Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume.
Abeles RD, Mullish BH, Forlano R, Kimhofer T, Adler M, Tzallas A, Giannakeas N, Yee M, Mayet J, Goldin RD, Thursz MR, Manousou P. Abeles RD, et al. Among authors: manousou p. Aliment Pharmacol Ther. 2019 Apr;49(8):1077-1085. doi: 10.1111/apt.15192. Epub 2019 Mar 5. Aliment Pharmacol Ther. 2019. PMID: 30836450 Free PMC article.
High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.
Forlano R, Mullish BH, Giannakeas N, Maurice JB, Angkathunyakul N, Lloyd J, Tzallas AT, Tsipouras M, Yee M, Thursz MR, Goldin RD, Manousou P. Forlano R, et al. Among authors: manousou p. Clin Gastroenterol Hepatol. 2020 Aug;18(9):2081-2090.e9. doi: 10.1016/j.cgh.2019.12.025. Epub 2019 Dec 27. Clin Gastroenterol Hepatol. 2020. PMID: 31887451 Free PMC article.
96 results